PBI-5D3H5

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePBI-5D3H5
Drug Alias Nameanti-CTLA-4 antibody (Premier Biomedical)CTLA-4 checkpoint inhibitor (Premier Biomedical)PBI-5D3H5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPremier Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPremier Biomedical Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A